Cost-Effectiveness of Femtosecond Laser-Assisted Cataract Surgery versus Phacoemulsification Cataract Surgery

Published:October 11, 2013DOI:


      To perform a comparative cost-effectiveness analysis (CEA) of femtosecond laser-assisted cataract surgery (LCS) and conventional phacoemulsification cataract surgery (PCS)


      Retrospective CEA using computer-based econometric modeling.


      Hypothetical cohort of patients undergoing cataract surgery in the better eye based on a review of the current literature and our direct experience using LCS.


      A cost-effectiveness decision tree model was constructed to analyze the cost-effectiveness of LCS compared with PCS. Complication rates of cataract surgery were obtained from a review of the current literature to complete the cohort of patients and outcomes. This data was incorporated with time trade-off utility values converted from visual acuity outcomes.

      Main Outcome Measures

      Improvements in best-corrected visual acuity obtained from the literature were used to calculate the increase in quality-adjusted life-years (QALYs) in a hypothetical cohort between 6 months and 1 year after cataract surgery. This was combined with approximate costs in a cost–utility analysis model to determine the incremental cost-effectiveness ratios (ICERs).


      Based on the simulated complication rates of PCS and LCS and assuming resultant visual acuity outcome improvement of 5% in uncomplicated cases of LCS, the cost-effectiveness (dollars spent per QALY) gained from LCS was not cost-effective at $92 862 Australian Dollars. The total QALY gain for LCS over PCS was 0.06 units. Multivariate sensitivity analyses revealed that LCS would need to significantly improve visual outcomes and complications rates over PCS, along with a reduction in cost to patient, to improve cost effectiveness. Modeling a best-case scenario of LCS with excellent visual outcomes (100%), a significant reduction in complications (0%) and a significantly reduced cost to patient (of $300) resulted in an ICER of $20 000.


      Laser cataract surgery, irrespective of potential improvements in visual acuity outcomes and complication rates, is not cost effective at its current cost to patient when compared with cost-effectiveness benchmarks and other medical interventions, including PCS. A significant reduction in the cost to patient (via reduced consumable/click cost) would increase the likelihood of LCS being considered cost effective.
      To read this article in full you will need to make a payment
      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nagy Z.Z.
        • Kránitz K.
        • Takacs A.I.
        • et al.
        Comparison of intraocular lens decentration parameters after femtosecond and manual capsulotomies.
        J Refract Surg. 2011; 27: 564-569
        • Filkorn T.
        • Kovács I.
        • Takács Á
        • et al.
        Comparison of IOL power calculation and refractive outcome after laser refractive cataract surgery with a femtosecond laser versus conventional phacoemulsification.
        J Refract Surg. 2012; 28: 540-544
        • Friedman N.J.
        • Palanker D.V.
        • Schuele G.
        • et al.
        Femtosecond laser capsulotomy.
        J Cataract Refract Surg. 2011; 37: 1189-1198
        • Abell R.G.
        • Kerr N.M.
        • Vote B.J.
        Femtosecond laser-assisted cataract surgery compared with conventional cataract surgery.
        Clin Experiment Ophthalmol. 2013; 41: 455-462
        • Conrad-Hengerer I.
        • Hengerer F.H.
        • Schultz T.
        • Dick H.B.
        Effect of femtosecond laser fragmentation on effective phacoemulsification time in cataract surgery.
        J Refract Surg. 2012; 28: 879-883
        • Palanker D.V.
        • Blumenkranz M.S.
        • Andersen D.
        • et al.
        Femtosecond laser-assisted cataract surgery with integrated optical coherence tomography.
        Sci Transl Med. 2010; 2: 58ra85
        • Takács A.I.
        • Kovács I.
        • Miháltz K.
        • et al.
        Central corneal volume and endothelial cell count following femtosecond laser-assisted refractive cataract surgery compared to conventional phacoemulsification.
        J Refract Surg. 2012; 28: 387-391
        • Sugar A.A.
        Ultrafast (femtosecond) laser refractive surgery.
        Curr Opin Ophthalmol. 2002; 13: 246-249
        • Masket S.
        • Sarayba M.
        • Ignacio T.
        • Fram N.
        Femtosecond laser-assisted cataract incisions: architectural stability and reproducibility [letter].
        J Cataract Refract Surg. 2010; 36: 1048-1049
        • Nubile M.
        • Carpineto P.
        • Lanzini M.
        • et al.
        Femtosecond laser arcuate keratotomy for the correction of high astigmatism after keratoplasty.
        Ophthalmology. 2009; 116: 1083-1092
        • Siegel J.E.
        • Weinstein M.C.
        • Russell L.B.
        • Gold M.R.
        Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses.
        JAMA. 1996; 276: 1339-1341
        • Weinstein M.C.
        • Siegel J.E.
        • Gold M.R.
        • et al.
        Panel on Cost-Effectiveness in Health and Medicine. Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
        JAMA. 1996; 276: 1253-1258
        • Abell R.G.
        • Kerr N.M.
        • Vote B.J.
        Toward zero effective phacoemulsification time using femtosecond laser pretreatment.
        Ophthalmology. 2013; 120: 942-948
        • Brown G.C.
        Vision and quality-of-life.
        Trans Am Ophthalmol Soc. 1999; 97: 473-511
        • Brown M.M.
        • Brown G.C.
        • Sharma S.
        • et al.
        Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.
        Arch Ophthalmol. 2002; 120: 481-484
        • Lansingh V.C.
        • Carter M.J.
        Use of global visual acuity data in a time trade-off approach to calculate the cost utility of cataract surgery.
        Arch Ophthalmol. 2009; 127: 1183-1193
        • Saw S.M.
        • Gazzard G.
        • Gomezperalta C.
        • et al.
        Utility assessment among cataract surgery patients.
        J Cataract Refract Surg. 2005; 31: 785-791
        • Mathers C.D.
        Gains in health expectancy from the elimination of diseases among older people.
        Disabil Rehabil. 1999; 21: 211-221
        • Riley A.F.
        • Malik T.Y.
        • Grupcheva C.N.
        • et al.
        The Auckland cataract study: co-morbidity, surgical techniques, and clinical outcomes in a public hospital service.
        Br J Ophthalmol. 2002; 86: 185-190
        • Busbee B.G.
        • Brown M.M.
        • Brown G.C.
        • Sharma S.
        Incremental cost-effectiveness of initial cataract surgery.
        Ophthalmology. 2002; 109 (discussion 612-3): 606-612
        • Lundström M.
        • Stenevi U.
        • Thorburn W.
        The Swedish National Cataract Register: a 9-year review.
        Acta Ophthalmol Scand. 2002; 80: 248-257
        • Lundström M.
        • Barry P.
        • Henry Y.
        • et al.
        Evidence-based guidelines for cataract surgery: guidelines based on data in the European Registry of Quality Outcomes for Cataract and Refractive Surgery database.
        J Cataract Refract Surg. 2012; 38: 1086-1093
        • Hahn U.
        • Krummenauer F.
        • Kölbl B.
        • et al.
        Determination of valid benchmarks for outcome indicators in cataract surgery: a multicenter, prospective cohort trial.
        Ophthalmology. 2011; 118: 2105-2112
        • Hoffmann P.C.
        • Hütz W.W.
        Analysis of biometry and prevalence data for corneal astigmatism in 23,239 eyes.
        J Cataract Refract Surg. 2010; 36: 1479-1485
        • Szigeti A.
        • Kránitz K.
        • Takács A.I.
        • et al.
        Comparison of long-term visual outcome and IOL position with a single-optic accommodating IOL after 5.5- or 6.0-mm femtosecond laser capsulotomy.
        J Refract Surg. 2012; 28: 609-613
        • Kránitz K.
        • Miháltz K.
        • Sándor G.L.
        • et al.
        Intraocular lens tilt and decentration measured by Scheimpflug camera following manual or femtosecond laser–created continuous circular capsulotomy.
        J Refract Surg. 2012; 28: 259-263
        • Kránitz K.
        • Takács Á.
        • Miháltz K.
        • et al.
        Femtosecond laser capsulotomy and manual continuous curvilinear capsulorrhexis parameters and their effects on intraocular lens centration.
        J Refract Surg. 2011; 27: 558-563
        • Roberts T.V.
        • Lawless M.
        • Bali S.J.
        • et al.
        Surgical outcomes and safety of femtosecond laser cataract surgery: a prospective study of 1500 consecutive cases.
        Ophthalmology. 2013; 120: 227-233
        • Kanthan G.L.
        • Wang J.J.
        • Rochtchina E.
        • et al.
        Ten-year incidence of age-related cataract and cataract surgery in an older Australian population: the Blue Mountains Eye Study.
        Ophthalmology. 2008; 115: 808-814
      1. Australian Bureau of Statistics. 4102.0-Australian Social Trends March 2011. Life expectancy trends - Australia. Available at:$File/41020_Lifeexpectancy_Mar2011.pdf. Accessed January 8, 2013.

      2. Australian Government Department of Health and Ageing. Cost report for Round 14 of the National Hospital Cost Data Collection for the 2009-2010 financial year. Dated November 2011. Available at:$File/R14CWNatEst_v6×.pdf. Accessed January 8, 2013.

      3. Pharmaceutical Benefits Scheme. Pharmaceutical Benefits Scheme Schedule. Available at: Accessed January 8, 2013.

        • Prabhu S.S.
        • Kaakeh R.
        • Sugar A.
        • et al.
        Comparative cost-effectiveness analysis of Descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States.
        Am J Ophthalmol. 2013; 155: 45-53
      4. World Health Organization. World Health Report 2002: World Health Report: Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization; 2002: The world health report 2002 - Reducing Risks, Promoting Health Life;p 108. Available at: Accessed January 9, 2013.

        • Taylor H.R.
        LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense.
        Am J Ophthalmol. 2007; 143: 1-8
        • Richardson A.K.
        Investing in public health: barriers and possible solutions.
        J Public Health (Oxf). 2012; 34: 322-327
        • Lundström M.
        • Behndig A.
        • Kugelberg M.
        Decreasing rate of capsule complications in cataract surgery: eight-year study of incidence, risk factors, and data validity by the Swedish National Cataract Register.
        J Cataract Refract Surg. 2011; 37: 1762-1767
        • Miller J.J.
        • Scott I.U.
        • Flynn Jr., H.W.
        • et al.
        Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment.
        Am J Ophthalmol. 2005; 139: 983-987
        • Mello Jr., M.O.
        • Scott I.U.
        • Smiddy W.E.
        • et al.
        Surgical management and outcomes of dislocated intraocular lenses.
        Ophthalmology. 2000; 107: 62-67
        • Nagy Z.Z.
        • Ecsedy M.
        • Kovács I.
        • et al.
        Macular morphology assessed by optical coherence tomography image segmentation after femtosecond laser-assisted and standard cataract surgery.
        J Cataract Refract Surg. 2012; 38: 941-946

      Linked Article

      • Re: Abell et al.: Cost-effectiveness of femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery (Ophthalmology 2014;121:10-6)
        OphthalmologyVol. 121Issue 10
        • In Brief
          We read with interest the recently published study by Abell et al,1 highlighting the economic issues of femtosecond laser-assisted cataract surgery (FCS). The authors used a decision tree model to estimate the cost effectiveness of FCS compared with phacoemulsification cataract surgery (PCS). They reported with transparency the way they elaborated the model and how they selected probabilities, costs, and utility values. After a deterministic sensitivity analysis using optimistic and pessimistic scenarios, they concluded that FCS failed to reach the threshold of cost-effectiveness, and that a reduction in the cost of FCS (including consumables) would increase the probability of FCS being cost effective.
        • Full-Text
        • PDF